Condition Guide
Peptides for IBD & Gut Healing
BPC-157 ("Body Protection Compound") was originally isolated from gastric juice and has dozens of preclinical studies documenting accelerated healing of GI ulcers, reduced colitis, and improved intestinal integrity.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
How peptides help
BPC-157 upregulates VEGF, modulates nitric oxide, and supports angiogenesis in damaged intestinal mucosa. Animal models of Crohn's-like disease, NSAID-induced ulcers, and colitis consistently show benefit.
Peptides researched for ibd & gut healing
State of the evidence
Preclinical data is extensive and consistent. Controlled human trials in IBD are limited, and BPC-157 is not FDA approved.
Frequently asked
Is BPC-157 effective for Crohn's disease?
Preclinical rodent data is robust. Human trial evidence is limited, and BPC-157 is not approved as a therapy. Patients should not substitute for proven IBD therapies.
Related articles & guides
What Are Peptides? A Science-Based Introduction
Guide · 12 min
FDA Regulation of Peptides: What You Need to Know
Guide · 10 min
Peptide Therapy: What You Need to Know Before Starting
Guide · 14 min
Peptides for Women: Safety, Benefits, and What’s Different
Deep Dive · 14 min
FDA Sets July 23–24 Meeting to Review BPC-157, TB-500, and 5 More Peptides for Compounding Access
Regulatory · 12 min
RFK Jr. Announces 14 Peptides Moving Back to Category 1: What It Means
Regulatory · 7 min
FDA Category 2 Peptide Ban: The Complete Guide
Regulatory · 7 min
Peptide Compounding in 2026: What Patients Need to Know
Guide · 5 min
BPC-157 Human Clinical Data: Where We Stand in 2026
Research · 6 min